Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2009 · fourth_quarter · Q4
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act Regulatory provisions related to Medicare Part D. Provisions included in health reform proposals that would impact Part D, such as formulary requirements, anti-kickback statutes for generic drug copay waivers, Medicaid rebate changes, direct negotiation.
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Source: Senate LDA
H.R. 1204 Community Pharmacy Fairness Act
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act Regulatory provisions related to Medicare Part D. Provisions included in health reform proposals that would impact Part D, such as formulary requirements, anti-kickback statutes for generic drug copay waivers, Medicaid rebate changes, direct negotiation.
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
America's Affordable Health Choices Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
American Recovery and Reinvestment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
American Recovery and Reinvestment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
American Recovery and Reinvestment Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act Regulatory provisions related to Medicare Part D. Provisions included in health reform proposals that would impact Part D, such as formulary requirements, anti-kickback statutes for generic drug copay waivers, Medicaid rebate changes, direct negotiation.
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act Regulatory provisions related to Medicare Part D. Provisions included in health reform proposals that would impact Part D, such as formulary requirements, anti-kickback statutes for generic drug copay waivers, Medicaid rebate changes, direct negotiation.
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
TRUST in Health Information Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Generic Pharmaceuticals, Healthcare Reform, Health Information Technology, Health Information Privacy, Antitrust, Comaprative Effectiveness Researc, Medicare Part D HR 971, H.R. 6898, H.R. 6357, HR 6331
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
Generic Pharmaceuticals, Healthcare Reform, Health Information Technology, Health Information Privacy, Antitrust, Comaprative Effectiveness Researc, Medicare Part D HR 971, H.R. 6898, H.R. 6357, HR 6331
Health-e Information Technology Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
Health-e Information Technology Act of 2008
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Generic Pharmaceuticals, Healthcare Reform, Health Information Technology, Health Information Privacy, Antitrust, Comaprative Effectiveness Researc, Medicare Part D HR 971, H.R. 6898, H.R. 6357, HR 6331
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
H.R. 1204 Community Pharmacy Fairness Act
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2009 · third_quarter · Q3
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
S. 1697 Affordable Health Choices Act S. 1796 America's Healthy Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 Promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmacy Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Healht IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2009 · second_quarter · Q2
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2009 · first_quarter · Q1
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2008 · fourth_quarter · Q4
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2008 · fourth_quarter · Q4
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
pharmaceuticals (HR 5629, HR 1038, s 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2008 · third_quarter · Q3
Generic Pharmaceuticals, Healthcare Reform, Health Information Technology, Health Information Privacy, Antitrust, Comaprative Effectiveness Researc, Medicare Part D HR 971, H.R. 6898, H.R. 6357, HR 6331
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2008 · third_quarter · RR
pharmaceuticals, healthcare reform, health information technology, health information privacy, antitrust, comparative effectiveness research, Medicare Part D
pharmaceuticals, healthcare reform, health information technology, health information privacy, antitrust, comparative effectiveness research, Medicare Part D
pharmaceuticals, healthcare reform, health information technology, health information privacy, antitrust, comparative effectiveness research, Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS)